Article information
Full text is only aviable in PDF
REFERENCES
[1]
J Bousquet, P van Cauwenberge, N Khaltaev.
ARIA Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma.
J Allergy Clin Immunol, 108 (2001), pp. 147334
[2]
C Bachert, A Vignola, P Gevaert, B Leynaert, P van Cawenberge, J Bousquet.
Allergic rhinitis, rhinosinusitis and asthma: one airway disease.
Immunol Allergy Clin N Am, 24 (2004), pp. 19-43
[3]
AL Valero.
Valoración de la obstrucción nasal.
Técnicas de exploración y diagnóstico nasal y sinusal, pp. 71-94
[4]
B Leynaert, F Neukirch, P Demoly, J Bousquet.
Epidemiologic evidence for asthma and rhinitis comorbidity.
J Allergy Clin Immunol, 106 (2000), pp. 201-205
[5]
R Beasley, U Keil, E von Mutius, N Pearce.
World wide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema: ISAAC.
Lancet, 351 (1998), pp. 1225-1232
[6]
B Leynaert, J Bousquet, C Neukirch, R Liard, F Neukirch.
Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey.
J Allergy Clin Immunol, 104 (1999), pp. 301-304
[7]
M Gaga, P Lambrou, N Papageorgiou, N Koulouris, E Kosmas, S Fragakis, et al.
Eosinophils are a feature of upper and lower airway pathology in non-atopic asthma, irrespective of the presence of rhinitis.
Clin Exp Allergy, 30 (2000), pp. 663-669
[8]
AL Wright, CJ Holberg, FD Martínez, M Halonen, W Morgan, LM Taussig.
Epidemiology of physician-diagnosed allergic rhinitis in childhood.
Pediatrics, 94 (1994), pp. 895-901
[9]
RJ Settipane, GW Hagy, GA Settipane.
Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students.
Allergy Proc, 15 (1994), pp. 21-25
[10]
S Guerra, DL Sherrill, FD Martínez, RA Barbee.
Rhinitis as an independent risk factor for adult-onset asthma.
J Allergy Clin Immunol, 109 (2002), pp. 419-425
[11]
JK Peat, CM Salome, AJ Woolcock.
Longitudinal changes in atopy during a 4-year period: relation to bronchial hyperresponsiveness and respiratory symptoms in a population sample of Australian schoolchildren.
J Allergy Clin Immunol, 85 (1990), pp. 65-74
[12]
JC Celedon, ME Soto-Quiros, LA Hanson, ST Weiss.
The relationship among markers of allergy, asthma, allergic rhinitis, and eczema in Costa Rica.
Pediatr Allergy Immunol, 13 (2002), pp. 91-97
[13]
KP Strohl, MJ Decker, LG Olson, TA Flak, PL Hoekje.
The nasal response to exercise and exercise induced bronchoconstriction in normal and asthmatic subjects.
Thorax, 43 (1988), pp. 890-895
[14]
R Shturman-Ellstein, RJ Zevallos, JM Buckley, JF Souhrada.
The beneficial effect of nasal breathing on exercise-induced bronchoconstriction.
Am Rev Respir Dis, 118 (1978), pp. 65-73
[15]
RL Wilber, KW Rundell, L Szmedra, DM Jenkinson, J Im, SD Drake.
Incidence of exercise-induced bronchospasm in Olympic winter sport athletes.
Med Sci Sports Exerc, 32 (2000), pp. 732-737
[16]
EM Karjalainen, A Laitinen, M Sue-Chu, A Altraja, L Bjermer, LA Laitinen.
Evidence of airway inflammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine.
Am J Respir Crit Care Med, 161 (2000), pp. 2086-2091
[17]
C Maiolo, L Fuso, A Todaro, F Anatra, V Boniello, S Basso, et al.
Prevalence of asthma and atopy in Italian Olympic athletes.
Int J Sports Med, 25 (2004), pp. 139-144
[18]
Global Initiative for asthma (GINA). Global strategy for asthma management and prevention. Bethesda MD. National Health Institute (NHI) publication number 02-3659. 2002.
[19]
J Bousquet, A Vignola, B Leynaert, P Demoly.
Links between rhinitis and asthma.
Allergy, 58 (2003), pp. 733-741
[20]
P Chánez, AM Vignola, P Vic, F Guddo, G Bonsignore, P Godard, et al.
Comparison between nasal and bronchial inflammation in asthmatic and control subjects.
Am J Respir Crit Care Med, 159 (1999), pp. 588-595
[21]
J Bousquet, W Jacot, A Vignola, C Bachert, P van Cawenberge.
Allergic rhinitis: a disease remodeling the upper airways?.
J Allergy Clin Immunol, 113 (2004), pp. 43-49
[22]
J Corren, A Adinoff, C Irvin.
Changes in bronchial responsiveness following nasal provocation con allergen.
J Allergy Clin Immunol, 89 (1992), pp. 611-618
[23]
M Schumacher, K Cota, L Taussig.
Pulmonary response to nasal-challenge testing of atopic subjects with stable asthma.
J Allergy Clin Immunol, 78 (1986), pp. 30-35
[24]
N Littell, C Carlisle, R Millman, S Braman.
Changes in airway resistance following nasal provocation.
Am Rev Respir Dis, 141 (1990), pp. 580-583
[25]
A Togias.
Systemic immunologic and inflammatory aspects of allergic rhinitis.
J Allergy Clin Immunol, 106 (2000), pp. S247-SS50
[26]
C McCusker, M Chicoine, D Hamid, B Mazer.
Site-specific sensitization in a murine model of allergic rhinitis: role of the upper airway in lower airway disease.
J Allergy Clin Immunol, 110 (2002), pp. 891-898
[27]
GJ Braunstahl, SE Overbeek, A KleinJan, JB Prins, HC Hoogsteden, WJ Fokkens.
Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways.
J Allergy Clin Immunol, 107 (2001), pp. 469-476
[28]
KM Beeh, J Beier, O Kornmann, C Meier, T Taeumer, R Buhl.
A single nasal allergen challenge increases induced sputum inflammatory markers in non-asthmatic subjects with seasonal allergic rhinitis: correlation with plasma interleukin-5.
Clin Exp Allergy, 33 (2003), pp. 475-482
[29]
J Chakir, M Laviolette, H Turcotte, M Boutet, LP Boulet.
Cytokine expression in the lower airways of nonasthmatic subjects with allergic rhinitis: influence of natural allergen exposure.
J Allergy Clin Immunol, 106 (2000), pp. 904-910
[30]
ME Boulay, LP Boulet.
Influence of natural exposure to pollen and domestic animals on airway responsiveness and inflammation in sensitized non-asthmatic subjects.
Int Arch Allergy Immunol, 128 (2002), pp. 336-343
[31]
GJ Braunstahl, WJ Fokkens, SE Overbeek, A KleinJan, HC Hoogsteden, JB Prins.
Mucosal and systemic inflammatory changes in allergic rhinitis and asthma: a comparison between upper and lower airways.
Clin Exp Allergy, 33 (2003), pp. 579-587
[32]
ME Boulay, LP Boulet.
Lower airway inflammatory responses to repeated very low dose allergen challenge in allergic rhinitis and asthma.
Clin Exp Allergy, 32 (2002), pp. 1441-1447
[33]
GJ Braunstahl, A KleinJan, SE Overbeek, JB Prins, HC Hoogsteden, WJ Fokkens.
Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients.
Am J Respir Crit Care Med, 161 (2000), pp. 2051-2057
[34]
GJ Braunstahl, SE Overbeek, WJ Fokkens, A KleinJan, AR McEuen, AF Walls, et al.
Segmental bronchoprovocation in allergic rhinitis affects mast cell and basophil numbers in nasal and bronchial mucosa.
Am Respir Crit Care Med, 164 (2001), pp. 858-865
[35]
ER McFadden Jr.
Exercise-induced airway narrowing.
Middleton's allergy principles and practice, pp. 1323-1332
[36]
HB Richardson, PM Slebohm.
Nasal airway response to exercise.
J Allergy, 41 (1968), pp. 269-284
[37]
NC Syabbalo, A Bundgaard, JG Widdicombe.
Effect of exercise on nasal airflow resistance in healthy subjects and in patients with asthma and rhinitis.
Bull Eur Physiopathol Respir, 21 (1985), pp. 507-513
[38]
LG Olson, KP Strohl.
The response of the nasal airway to exercise.
Am Rev Respir Dis, 135 (1987), pp. 356-359
[39]
J Serra-Batlles, JM Montserrat, J Mullol, E Ballester, A Xaubet, C Picado.
Response of the nose to exercise in healthy subjects and in patients with rhinitis and asthma.
Thorax, 49 (1994), pp. 128-132
[40]
YJ Jang, JH Lee, JY Jang.
Acoustic rhinometric evaluation of the nasal response to exercise in patients with nasal septal deviation.
Clin Otolaryngol, 25 (2000), pp. 423-427
[41]
KP Strohl, JL Arnold, MJ Decker, PL Hooekje, CF Doershuk, RC Stern.
The nasal response to exercise in patients with cystic fibrosis.
Rhinology, 30 (1992), pp. 241-248
[42]
SL Harlin, DG Ansel, SR Lane, J Myers, GM Kephart, GJ Gleich.
A clinical and pathologic study of chronic sinusitis: the role of the eosinophil.
J Allergy Clin Immunol, 81 (1988), pp. 867-875
[43]
DL Hamilos, DY Leung, R Wood, A Meyers, JK Stephens, J Barkans, et al.
Chronic hyperplastic sinusitis: association of tissue eosinophilia with mRNA expression of granulocyte-macrophage colony-stimulating factor and interleukin-3.
J Allergy Clin Immunol, 92 (1993), pp. 39-48
[44]
R Jankowski, F Bouchoua, L Coffinet, JM Vignaud.
Clinical factors influencing the eosinophil infiltration of nasal polyps.
Rhinology, 40 (2002), pp. 173-178
[45]
M Bresciani, L Paradis, A Des Roches, H Vernhet, I Vachier, P Godard, et al.
Rhinosinusitis in severe asthma.
J Allergy Clin Immunol, 107 (2001), pp. 73-80
[46]
MP Berges-Gimeno, RA Simon, DD Stevenson.
The natural history and clinical characteristics of aspirin-exacerbated respiratory disease.
Ann Allergy Asthma Immunol, 89 (2002), pp. 474-478
[47]
J Altamura Namazy, RA Simon.
Sensitivity to nonsteroidal antiinflammatory drugs.
Ann Allergy Asthma Immunol, 89 (2002), pp. 542-550
[48]
LHP Nguyen, JJ Manoukian, SE Sobol, TL Tewfik, BD Mazer, MD Schloss, et al.
Similar allergic inflammation in the middle ear and the upper airway: evidence linking otitis media with effusion to the united airways concept.
J Allergy Clin Immunol, 114 (2004), pp. 1110-1115
[49]
J Kaufman, G Wright.
The effect of nasal and nasopharyngeal irritation on airway resistance in man.
Am Rev Respir Dis, 100 (1969), pp. 626-630
[50]
J Kaufman, J Chen, G Wright.
The effect of trigeminal resection on reflex bronchoconstriction after nasal and nasopharyngeal irritation in man.
Am Rev Respir Dis, 101 (1970), pp. 768-769
[51]
A Togias.
Rhinitis and asthma: evidence for respiratory system integration.
J Allergy Clin Immunol, 111 (2003), pp. 1171-1183
[52]
P Bardin, B van Heerden, J Joubert.
Absence of pulmonary aspiration of sinus contents in patients with asthma and sinusitis.
J Allergy Clin Immunol, 86 (1990), pp. 82-88
[53]
Z Csoma, S Kharitonov, B Balint, A Bush, N Wilson, P Barnes.
Increased leukotrienes in exhaled breath condensate in childhood asthma.
Am J Respir Crit Care Med, 166 (2002), pp. 1345-1349
[54]
A Togias, A Bieneman, D Bloom, R Schleimer, D Lezzoni, A Harris, et al.
Changes in blood leucocyte cytokine expression following repeated nasal allergen provocation: evidence for systemic manifestations.
J Allergy Clin Immunol, 109 (2002), pp. 262
[55]
J Magnusson, X Ping Lin, A Dahlman-Höglund, LA Hanson, E Telemo, O Magnusson, et al.
Seasonal intestinal inflammation in patients with birch pollen allergy.
J Allergy Clin Immunol, 112 (2003), pp. 45-51
[56]
A Sandrini, IM Ferreira, JR Jardim, N Zamel, KR Chapman.
Effect of nasal triamcinolone acetonide on lower airway inflammatory markers in patients with allergic rhinitis.
J Allergy Clin Immunol, 111 (2003), pp. 313-320
[57]
B Pedersen, R Dahl, N Lindqvist, N Mygind.
Nasal inhalation of the glucocorticoid budesonide from a spacer for the treatment of patients with pollen rhinitis and asthma.
Allergy, 45 (1990), pp. 451-456
[58]
WT Watson, AB Becker, FE Simons.
Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness.
J Allergy Clin Immunol, 91 (1993), pp. 97-101
[59]
RJ Adams, AL Fuhlbrigge, JA Finkelstein, ST Weiss.
Intranasal steroids and the risk of emergency department visits for asthma.
J Allergy Clin Immunol, 109 (2002), pp. 636-642
[60]
J Crystal-Peters, C Neslusan, WH Crown, A Torres.
Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma related hospitalizations and emergency department visits.
J Allergy Clin Immunol, 109 (2002), pp. 57-62
[61]
JM Pinto, P Assanasen, FN Barody, E Naureckas, J Solway, RM Naclerio.
Treatment of nasal inflammation decreases the ability of subjects with asthma to condition inspired air.
Am J Respir Crit Care Med, 170 (2004), pp. 863-869
[62]
JA Grant, CF Nicodemus, SR Findlay, MM Glovsky, J Grossman, H Kaiser, et al.
Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized controlled trial.
J Allergy Clin Immunol, 95 (1995), pp. 923-932
[63]
J Corren, AG Harris, D Aaronson, W Beaucher, R Berkowitz, E Bronsky, et al.
Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and asthma.
J Allergy Clin Immunol, 100 (1997), pp. 781-788
[64]
G Ciprandi, MA Tosca, G Passalacqua, GW Canonica.
Long-term cetirizine treatment reduces allergic symptoms and drug prescriptions in children with mite allergy.
Ann Allergy Asthma Immunol, 87 (2001), pp. 222-226
[65]
CE Baena-Cagnani, WE Berger, LM duBuske, SE Gume, P Stryszak, R Lorber, et al.
Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma.
Int Arch Allergy Immunol, 130 (2003), pp. 307-313
[66]
MJ Abramson, RM Puy, JM Weiner.
Inmunoterapia con alergenos para el asma. In: La Cochrane Library plus en español, Update Software. CD001186-ES, (2003),
[67]
DR Wilson, M Torres Lima, SR Durham.
Inmunoterapia sublingual para la rinitis alérgica.
La Cochrane Library plus en español, Update Software. CD002893-ES, (2003),
[68]
WHO Position Paper: allergen immunotherapy: therapeutic vaccines for allergic diseases.
Allergy, 53 (1998), pp. 1-42
[69]
C Moller, S Dreborg, HA Ferdousi, S Halken, A Host, L Jacobsen, et al.
Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).
J Allergy Clin Immunol, 109 (2002), pp. 251-256
[70]
AM Vignola, M Humbert, J Bousquet, LP Boulet, S Hedgecock, M Blogg, et al.
Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.
Allergy, 59 (2004), pp. 709-717
Copyright © 2005. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
